PubMed · 1987 · 51 citations · 23 references
MedicineOncologyToxicologyCarcinogenesisDrug MetabolismMetabolismCarcinogen MetabolismCarcinogenic MechanismsChemical CarcinogenesisGenotoxic CarcinogenesisHepatic MetabolismHepatocellular CarcinomaCarcinogenic Hepatic EffectsDna Synthesis InhibitionHepatic Cell Culture ModelsHigh-performance Liquid ChromatographyHigh-performance Liquid Chromatography AnalysisMetabolically Activated GenotoxicityUnscheduled Dna Synthesis Assay
The cell line HepG2 is derived from a well differentiated human hepatoblastoma, which retains many of the morphological characteristics of liver parenchymal cells. These cells at passages greater than 95 were found to metabolically activate carcinogens to genotoxic metabolites. The addition of 6.8 microM 1-methyl-3-nitro-1-nitrosoguanidine, 5.3 microM 4-nitroquinoline-N-oxide, and 4-20.3 microM 1-nitropyrene resulted in the induction of mutations at the HGPRT locus as determined by 6-thioguanine resistance. This is the first description of the induction of mutations in these cells. Additionally, unscheduled DNA synthesis in the presence of 4 mM hydroxyurea was increased by 9% with 5.3 microM 4-nitroquinoline-N-oxide, 57% with 13.6 microM 1-methyl-3-nitro-1-nitrosoguanidine, and 300% with 8.2 microM 1-nitropyrene. High performance liquid chromatographic analysis of metabolites formed following incubation of HepG2 with either [3H]-1-nitropyrene or [14C]benzo(a)pyrene demonstrate the occurrence of arene oxidation as well as nitroreduction.
23
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
David P. Aden, Alice Fogel, Stanley A. Plotkin et al. · Nature · 1979 · 1.3K citations
Medicine, Biochemistry, Oncology +5
HEPATOMAS IN TISSUE CULTURE COMPARED WITH ADAPTING LIVER IN VIVO.
Pitot Hc, Carl Peraino, Morse Pa et al. · PubMed · 1964 · 318 citations
Medicine, Cell Biology, Pathology +10